# Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM)

> **NCT00829218** · NA · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 60 (actual)

## Conditions studied

- Irritable Bowel Syndrome
- Fibromyalgia

## Interventions

- **OTHER:** Glutamate additive-free diet
- **OTHER:** Placebo diet

## Key facts

- **NCT ID:** NCT00829218
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-11
- **Final completion:** 2010-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00829218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00829218, "Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00829218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*